THEMAVEN, INC. (OTCMKTS:MVEN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

THEMAVEN, INC. (OTCMKTS:MVEN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 9, 2019, TheMaven, Inc. (the “Company”) announced the appointment of William Sornsin as the Company’s Chief Operating Officer. Mr. Sornsin has been with the Company since 2016 and has filled various roles with the Company since that time. Mr. Paul Edmondson, who had also held the position of Chief Operating Officer, will continue as the Company’s President.

On December 9, 2019, Company announced the appointment of Mr. Avi Zimak as the Company’s Chief Revenue Officer and Head of Global Strategic Partnerships. Mr. Zimak, who will be located in the Company’s New York City office, will be employed on a full time basis, at an annual salary of $450,000. Mr. Zimak will be paid a signing bonus of $250,000, subject to recapture in certain circumstances if Mr. Zimak’s employment ends before the second anniversary of the date of his employment agreement. Mr. Zimak will be eligible for an annual bonus of up to $450,000, based on the achievement in each calendar year of defined annual revenue targets, calculated on a quarterly basis, and paid quarterly subject to an annual reconciliation. Mr. Zimak will be granted a ten-year option to purchase up to an aggregate of 2,250,000 shares of common stock of the Company under the 2019 Equity Incentive Plan. This option will vest as to 1,125,000 shares, in three equal installments, based on performance targets tied to the achievement of established annual revenue targets for fiscal years 2020 to and including 2022. The remaining 1,250,000 shares will vest as follows: 1/3 will vest after 12 months from the date of the employment agreement; and then 1/36th will vest at the end of each month thereafter, concluding 36 months from the effect date of the employment agreement. Currently these options are unfunded, and the Company has agreed to timely increase the availability of shares of common stock to permit the exercise of the options upon vesting. Mr. Zimak will also participate in any broad based grant of options issued to the C-Suite executives on the same terms and pro rata basis. At the commencement of the employment, Mr. Zimak will also be awarded restricted stock units for 250,000 shares of common stock, vesting one year after the date of the employment agreement, with the shares to be delivered on the fifth anniversary of the date of the employment agreement. Mr. Zimak will be reimbursed for typical business expenses, provided with time off based on the C-Suite policies of the Company, and provided typical health and other benefits provided to the Company executive officers. The term of the employment agreement is for an initial period of two years, and it is automatically renewed for one additional year periods thereafter if not previously terminated. The employment agreement has early termination provisions for cause, permanent incapacity, and death. Mr. Zimak has the right to terminate for good reason in certain circumstances. In the event of certain of the early termination events, the Company will be obligated to pay salary compensation, bonus amounts and various of the restricted stock units will continue to vest. In the event of termination, the vested options and further vesting will be governed by the terms of the option grant and the plan under which they are granted. During the employment period and for one year thereafter, Mr. Zimak will be subject to the Company’s typical non-solicitation and competition provisions for all executive employees. Mr. Zimak will also entered in the standard Company confidentiality and proprietary rights agreement.

Before joining the Company, Mr. Zimak served as Chief Revenue Officer & Publisher of New York Media from March 2017 to December 2019 when the company was acquired by Vox Media. From September 2012 to January 2015 Mr. Zimak was VP, Sales of North America for Outbrain prior to being promoted to VP, General Manager of The Americas from January 2015 to February 2017. Before that, he served on various management teams at Hearst Corporation from August 2007 to September 2012, including the launch and oversight of the Hearst App Lab. He also served in national sales roles for Condé Nast from 2003 to 2007, Time Inc. from 2001 to 2003, Advance Publications American City Business Journals from 1998 to 2001 and Ziff Davis from 1997 to 1998. Mr. Zimak received his Bachelor of Arts from the State University of New York at Potsdam in 1997.

Mr. Andrew Kraft, the former Chief Revenue Officer and Head of Global Strategic Partnerships, will continue with the Company Supporting Venture Integration for a transition period, while he pursues other employment opportunities.


About THEMAVEN, INC. (OTCMKTS:MVEN)

Story continues below

theMaven, Inc., formerly Integrated Surgical Systems, Inc., is a development-stage company. The Company is engaged in developing a network of professionally managed online media channels, with an underlying technology platform. The Company offers theMaven platform, which is a group media network featuring content across multiple content segments. The Company’s platform provides value to independent publishers through distribution; engagement for their content and community; monetization through a range of advertising partnerships and membership programs, and tools to manage their audience and growth. It focuses on operating each channel by a Channel Partner drawn from subject matter experts, reporters, group evangelists and social leaders. The Company operates a Website at themaven.net. It focuses on incorporating mobile, video, communications, social, notifications and other technology into its theMaven platform, including DevOps processes and a cloud-based back-end.

An ad to help with our costs